Barclays upgrades Morgan Stanley [MS]‎ to an Overweight rating

Barclays took its ‎Morgan Stanley [NYSE:MS]‎‎ rating to the equivalent of Overweight from Equal-‎Weight, ‎in a research note dated January 4, 2021. Other analysts also revised their coverage, with ‎Citigroup’s analysts downgrading the shares from “a ‎Buy” rating to “a Neutral” rating in a research note ‎to investors issued in early November. In addition, ‎there was a new coverage from Seaport Global ‎Securities on July 08, 2020. The research firm rated MS ‎‎”a Buy”.

Get the ‎hottest stocks to trade every day before the market ‎opens 100% free. Click here ‎now. 

Is Morgan Stanley [NYSE:MS] a Good ‎Buy Right Now?

It ‎should be noted that MS technical indicators for short, intermediate as well as ‎long term progress have ‎placed an overall average of 100% as Buy. The average signal changed from ‎‎100% Buy in the last week ‎and compares with 100% Buy in the past month. Data from Morgan Stanley’s ‎Trend Spotter indicated ‎that the signals were Weakest. The stock current average is 8.87 million shares ‎in the past 20 days and ‎the short term average signal indicates a 100% Buy. In the last 50 days, the ‎average trading volume was ‎‎11.24 million shares while the medium term average advocated for 100% ‎Buy. The average long-term ‎signal stands at 100% Buy and the 100-day average volume stands at 11.2 ‎million shares.

MS Price ‎Performance

On Wall Street, Morgan Stanley [NYSE:MS] finished ‎Thursday’s session up 1.02% at ‎‎$68.53. The stock went up to $68.74 at the same session while its ‎lowest single day price was $67.41. In ‎the last five days, it saw a rise of about 0.47%, Morgan Stanley ‎shares gained by almost 34.06% since ‎the beginning of the year. However, the share price has dropped ‎to as low as -0.64% below its one ‎year high. On 12/23/20, the company shares recorded $68.97, the ‎highest single-day price it has got to ‎in the last 52-weeks and a 52-week low was seen on 03/18/20, the ‎same year at $27.20. The company’s ‎shares have inclined by 31.69% in the past year. The 50-day SMA ‎achieved is $59.53 while the 200-day ‎SMA is $49.18. Volume gained to 5.3 million from 5.28 million in ‎the previous session.

Morgan ‎Stanley [MS] Valuation Measures

Notably, Morgan Stanley ‎‎[MS] stock can be classified as a good ‎candidate in the listing of underestimated low-priced Capital ‎Markets companies to purchase soonest ‎possible with the prevailing 12-month PE ratio of 11.56. The ‎measure means the stock is exchanging at ‎a discount as compared to the 17.66x trailing earnings of the ‎industry. It can be helpful for investors to ‎consider historical price-sales ratio, more specifically, a 2.39 ‎PS value ratio is reported for the last one ‎year of reported earnings. That is lower than the industry ‎average of 3.63 which means MS serve an ‎attractive investment opportunity compared to its ‎competitors.

MS Stock Support And Resistance ‎Levels

On the 24-hour scale, the immediate ‎backing is perceived around 67.71 level, and in case ‎of violation of this particular level, it will cause ‎more drop to 66.90 level. On the upper level, 69.56 is still ‎the key resistance. The stock may increase to ‎the subsequent resistance at 69.04. The Relative ‎Strength Index (RSI) pinned on the 14-day chart is ‎‎68.94, implying a neutral technical stance while the ‎MACD stands at 1.95, meaning price will increase in ‎the next trading period. Percent R indicator moved ‎to 6.19%, implying bullish price movement. ‎Stochastic %K at 86.73% suggest selling the ‎stock.

What is the short interest in Morgan ‎Stanley?

Short interest in the Morgan Stanley ‎stock has plunged, decreasing by -4.65 million ‎shares to total 27.76 million shares on Dec 14, 2020. The ‎interest had seen shares on Nov 12, 2020 stand ‎at 23.11 million, data from Yahoo Finance shows. The ‎increase of 16.75% suggests the stock saw some ‎increased bearish sentiment. The stock’s days to ‎cover (short ratio) moved to while the shorted shares ‎account for just 1.94% of the overall float for the ‎stock.

Morgan Stanley’s Biggest Shareholders: ‎Who Owns Morgan Stanley [MS]?

Filings by ‎SSgA Funds Management, Inc. showed that the firm ‎now holds a total of 120,398,394 shares or roughly ‎‎6.66% of the outstanding MS shares. This means ‎their shares have reduced by -1,049,455 from the ‎‎120,398,394 the investor reportedly held in its prior ‎‎13-F filing. With the conclusion of the sale, The ‎Vanguard Group, Inc. updated stake is worth ‎‎$7,092,536,180. Details in the latest 13F filings reveal that ‎T. Rowe Price Associates, Inc. disposed off ‎their -6.79% stake valued at $6,258,843,151 while BlackRock ‎Fund Advisors added theirs at ‎‎$3,910,426,973. During the last quarter, T. Rowe Price Associates, Inc. ‎liquidated -7,369,552 of its shares ‎in Morgan Stanley while BlackRock Fund Advisors bought 502,472 ‎shares. The JPMorgan Investment ‎Management, I’s holdings currently number 35,782,293 shares at ‎‎$2452160539.29. According to the ‎firm’s last 13F report, Geode Capital Management LLC shares in the ‎company at filing stood at ‎‎21,706,615 shares, roughly $1,342,120,005.

MS Earnings Forecast For The ‎Current ‎Quarter

Morgan Stanley [MS] is expected to report weak earnings results for the quarter ‎ending ‎on Dec 2020. Consensus estimates give the company expected revenues of $11.01B and an ‎earnings ‎per share of $1.15 for Dec 2020. Looking further ahead, the company is expected to report ‎revenue of ‎‎$11.64B at an EPS of $1.38 for Mar 2021. The estimates represent upside of -0.20% and -‎‎10.13% in the ‎company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

MS Earnings Estimates For The ‎Current ‎Year

For the financial year, Morgan Stanley [NYSE:MS] is expected to bring in revenue of ‎‎$45.48B. ‎The returns are nearly $4.06 billion higher than the company’s actual revenue recorded in the ‎fiscal ‎year 2019. In terms of EPS for the 2020, estimate put it at 5.74, higher than that of FY19 by ‎‎$0.55. ‎Estimates put this year’s earnings growth at 10.60%, -10.10% for the next, and at an annual ‎‎3.72% over ‎the next 5-year period. As for sales, forecasts are for an increase of 9.80% in the current ‎fiscal year and ‎a further -0.20% over the following year.‎

Related posts